Clinical Trial Update: Vasomotor Symptoms (VMS) Progesterone Study: Vasomotor Symptoms and Endothelial Function - Trial of Oral Micronized Progesterone [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating oral micronized progesterone for vasomotor symptoms in menopause, with a focus on endothelial fu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Oral micronized progesterone (progesterone)

Snippet

Sponsor: University of British Columbia | Conditions: Menopause | Phase 2 | Status: UNKNOWN